| Please register to receive the benefits of our network-wide features. |
|
Dr. Moira Gunn interviews Craig Wheeler, CEO of Moementa Pharmaceuticals, who discusses biologics and the new biosimilars bill in Congress.
This free podcast is from our Tech Nation series.
For The Conversations Network: